Damla Günenç Eşim

12PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer.

|Oct 27, 2026
Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study.

|Sep 15, 2026
Tumour-Stroma Ratio and Platinum Resistance in Epithelial Ovarian Cancer: An Exploratory Analysis.

|Jul 28, 2026
Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study.

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|Mar 28, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

Pageof 2

Frequent Collaborators

4 joint publications

Özlem Kutlu

3 joint publications

Gürkan Gül

3 joint publications

Özlem Özdemir

3 joint publications

Halil Taşkaynatan